Veramarx, Inc.

Veramarx offers the only accurate diagnostic test for early-stage Lyme disease.

  • Stage Full Product Ready
  • Industry Healthcare Services
  • Location Boulder, CO, US
  • Currency USD
  • Founded January 2012
  • Employees 2
  • Incorporation Type C-corp
  • Website veramarx.com

Company Summary

Veramarx offers the only accurate diagnostic test for early-stage Lyme disease, which is one of the fastest growing infectious disease in the US and Western Europe. Lyme disease can only be treated effectively when diagnosed at the early stage of infection, when 75% of patients visit the doctor. Current tests are highly inaccurate, missing over 60% of the cases in the early stage.

Team

  • Whitney Richards
    Founder & CEO

    Whitney founded Veramarx because of his own experience with Lyme disease.

    Entrepreneur, M&A and financial services executive:
    ∞ CEO/General Manager, Aboca, USA
    ∞ CEO, Pop n’ Shake Development
    ∞ Structured Products Trader, Credit Suisse First Boston and 21st Securities
    ∞ Institutional Trader & Investment Advisory Board, West Peak Investment Advisors

  • David Macdonald
    Co-Founder, Executive Board Member

    Mr. Macdonald has a strong track record of success with more than 25 years of international experience developing and commercializing clinical diagnostic products and laboratory services. Mr. Macdonald has served in CEO and COO roles for over 20 years, most recently as the CEO at Agendia, and formerly as a Division President, COO and Vice President at Quest Diagnostics.

Previous Investors

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free